CClinicalTrials.gg
CompletedNCT03447392Updated Feb 27, 2018

Discharge Education of Integrated Traditional and Western Medicine Reduces Re-hospitalization in Patients With Chronic Heart Failure

An interventional study of Discharge Education of Chinese Medicine in Heart Failure, sponsored by Guangzhou University of Traditional Chinese Medicine. Completed at 1 site in China. Open to participants aged 40 Years to 85 Years. Per ClinicalTrials.gov, last updated 2018-02-27.

Sponsored by Guangzhou University of Traditional Chinese Medicine · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
134
Allocation
Randomized
Ages
40 Years to 85 Years
Sex
All
01

Study summary

Although interventions combining patient education and postdischarge management have demonstrated benefits in patients with chronic heart failure, the benefit attributable to patient education alone is not known. The investigators hypothesized that a patient discharge education program would improve clinical outcomes in patients with chronic heart failure.

Read the detailed description

Although interventions combining patient education and postdischarge management have demonstrated benefits in patients with chronic heart failure, the benefit attributable to patient education of Integrated Traditional and Western Medicine is not known. The investigators hypothesized that a patient discharge education of Integrated Traditional and Western Medicine program would improve clinical outcomes in patients with chronic heart failure.

02

Conditions studied

  • Heart Failure

Browse trials for

Keywords

  • Patient Education
  • Chinese Medicine
03

Who can participate

Ages eligible
40 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Candidates for this study were admitted to the hospital with a diagnosis of heart failure and documented left ventricular systolic dysfunction (ejection fraction\<0.40).

Exclusion criteria

Exclusion Criteria:

  • CKD4 and CKD5
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
134 participants (actual)

Study arms

  • Experimental
    patient education and Chinese medicine

    1-hour, one-on-one teaching session with a educator to the standard discharge education of Integrated Traditional and Western Medicine

    Behavioral: Discharge Education of Chinese Medicine

  • No intervention
    patient education

    no discharge education

Interventions

  • BehavioralDischarge Education of Chinese Medicine

    Discharge Education of Integrated Traditional and Western Medicine

05

What researchers measure

Primary outcomes

  1. total number of days hospitalized

    total number of days hospitalized in the 84-day follow-up period.

    Time frame: 84 days

06

Study locations

1 site
  • Guangdong Provincial Hospital of Traditional Chinese Medicine
    Guangzhou, Guangdong 510405, China
07

Registry details

Key details

Study ID
NCT03447392
Lead sponsor
Guangzhou University of Traditional Chinese Medicine
Responsible party
Sponsor
First posted
Feb 27, 2018
Start date
Aug 21, 2017
Primary completion
Jan 8, 2018
Completion
Jan 8, 2018
Last update
Feb 27, 2018

Study contacts

Xu ZOU
study chair · The Second Clinical College, Guangzhou University of Chinese Medicine

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion